Sara J. Hooshmand

Sara J. Hooshmand

Auto-generated profile, based on publicly available information

Sara J. Hooshmand

Department of Neurology, Mayo Clinic, Rochester, MN, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2024 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
BKBoyoung M. Kim
Boyoung M. Kim
KWKenny Y. Wang
Kenny Y. Wang
TXTimothy T. Xu
Timothy T. Xu
SHSara J. Hooshmand
Sara J. Hooshmand
GTGary N. Toups
Gary N. Toups
JCJohn Chen
John Chen

1 December 2021 in Journal of Clinical Neuromuscular Disease
Verified
Journal Article
Closed access
SRSwathi Beladakere Ramaswamy
Swathi Beladakere Ramaswamy
SSShivangi Singh
Shivangi Singh
SHSara Hooshmand
Sara Hooshmand
CJCho Junsang
Cho Junsang
MSMegan Sweeney
Megan Sweeney
RGRaghav Govindarajan
Raghav Govindarajan
Myasthenia gravis (MG) is one of the extensively studied autoimmune disorder. There has been a dramatic increase in research to further understand molecular pathogenesis of MG and clinical trials for new drugs in MG treatment in the past decade. This review article is to consolidate the available information in simple terms with students, residents, and fellows as target audience for easy learning and help application of this knowledge to clinical practice.

1 January 2022 in Therapeutic Advances in Ophthalmology
Verified
Journal Article
Open access
SHSara Hooshmand
Sara Hooshmand
JVJackson Voss
Jackson Voss
MHMatthew Hirabayashi
Matthew Hirabayashi
LMLindsey McDaniel
Lindsey McDaniel
JAJella An
Jella An
Background: Micro-pulse transscleral cyclophotocoagulation (MP-TSCPC) has continued to gain popularity as a treatment in adult glaucoma patients. Thus far there is limited evidence reporting the efficaciousness and safety of retreatment. Objective: To evaluate safety and efficacy of primary and repeat MP-TSCPC procedures. Methods: Thirty-four of 67 eyes who failed to achieve target IOP from initial MP-TSCPC underwent repeat MP-TSCPC and followed for a minimum of 6 months. All treatments were performed using the laser power of 2000 or 2250 mW, duration of 100–200 s, and a velocity 16–20 s per hemisphere swipe. Success criteria were defined as intraocular pressure (IOP) reduction of greater than 20% from baseline or any medication reduction without additional glaucoma procedures at 6 months after repeat MP-TSCPC. The 6-month success rate after repeat MP-TSCPC was also compared to that of initial MP-TSCPC in the same group of eyes. Results: Mean baseline IOP before the repeat MP-TSCPC was 23.0 + /- 5.3 on 3.0 + /- 1.4 medications. At 6 months, mean post-op IOP was 18.2 + /- 5.4 (21.9% reduction, p < 0.002), with mean medication staying relatively the same ( p = .976). Success rate was increased from 23.5% to 44.1% with the repeat procedure compared to that of initial procedure ( p = 0.123). Mean IOP reduction was also greater after repeat MP-TSCPC (18.7%, p < 0.002) when compared to initial MP-TSCPC (10.4%). No adverse events occurred. Conclusions: MP-TSCPC is a safe and effective non-invasive means to lower IOP in a variety of glaucoma patients. While over 50% (34/67) of eyes required repeat MP-TSCPC, repeat treatment resulted in greater success rates and IOP reduction without any adverse events when using the total energy between 112 and 150 J.

31 May 2023 in Journal of Movement Disorders
Verified
Journal Article
Open access
PDF file
EBElke Schipani Bailey
Elke Schipani Bailey
SHSara J. Hooshmand
Sara J. Hooshmand
NBNegin Badihian
Negin Badihian
PSPaola Sandroni
Paola Sandroni
EBEduardo E. Benarroch
Eduardo E. Benarroch
ECElizabeth A. Coon
Elizabeth A. Coon
Objective Multiple system atrophy (MSA) is characterized by urinary dysfunction, yet the influence of sex and gender on urinary symptoms and treatment is unclear. We sought to characterize sex and gender differences in the symptomatology, evaluation, and management of urinary dysfunction in patients with MSA.Methods Patients with MSA evaluated at our institution were reviewed and stratified by sex.Results While the prevalence of urinary symptoms was similar in male and female patients, incontinence was more common in females. Despite this, males and females underwent postvoid residual (PVR) measurement at similar rates. While catheterization rates were similar when PVR was measured, males were more than twice as likely to be catheterized than females in the absence of PVR measurement.Conclusion Urinary symptoms are common in MSA, but their presentation differs between males and females. The difference in catheterization rates may be driven by a gender disparity in referrals for PVR, which can guide treatment.

19 August 2025 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
SHSara J. Hooshmand
Sara J. Hooshmand
NVNisa Vorasoot
Nisa Vorasoot
XLXiaoyang Li
Xiaoyang Li
JCJohn Chen
John Chen
VRVyanka Redenbaugh
Vyanka Redenbaugh
EFEoin P Flanagan
Eoin P Flanagan
Background: Acute disseminated encephalomyelitis (ADEM) is a demyelinating syndrome observed in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) but there are limited data on application of this definition to its cerebral attacks or in adults with this disease. Methods: We analyzed patients from the Mayo Clinic MOGAD cohort ( n = 263) with cerebral attacks. We assessed whether children (<18 years-old) and adults (⩾18 years-old) fulfilled the 2013 ADEM definition. Results: We identified 89 patients (children, 34; adults, 55) and 55/89 (62%) were of female sex. Acute magnetic resonance imaging (MRI) abnormalities included: poorly demarcated T2 lesions (white matter, 85 (96%); deep gray matter, 41 (46%); T1-hypointense lesions (42 (47%)). Forty-two patients did not fulfill the ADEM definition due to: monofocal syndrome, 9; or no encephalopathy, 33. The remaining 47 patients (53%: children, 27/34 (79%); adults, 20/55 (36%)) fulfilled the ADEM definition, and 14 had preceding attacks, and 34 had subsequent attacks relative to ADEM episode. The features in children and adults with ADEM were broadly comparable. Conclusion: Applying the ADEM definition to MOGAD cerebral attacks highlighted that an update of the 2013 ADEM definition would be beneficial and could explicitly state its application to both adults and children and allow it to be applied to attacks at any time during the disease course.

24 September 2024 in Neurology
Verified
Journal Article
Closed access
CIChristopher Y. Itoh
Christopher Y. Itoh
KGKim J. Griffin
Kim J. Griffin
DYDongni Yi
Dongni Yi
SHSara J. Hooshmand
Sara J. Hooshmand
LWLauren Webb
Lauren Webb
RMRafid Mustafa
Rafid Mustafa